Qube Research & Technologies (QRT)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Sell
103,700
-39,100
-27% -$39.9M 0.12% 224
2026
Q1
$131M Sell
142,800
-61,700
-30% -$62.6M 0.15% 158
2025
Q4
$220M Sell
204,500
-34,200
-14% -$32.7M 0.22% 82
2025
Q3
$182M Buy
238,700
+22,700
+11% +$16.9M 0.19% 119
2025
Q2
$168M Buy
216,000
+25,900
+14% +$20.1M 0.17% 135
2025
Q1
$157M Buy
190,100
+85,300
+81% +$71M 0.18% 132
2024
Q4
$80.9M Buy
104,800
+10,000
+11% +$8.28M 0.11% 237
2024
Q3
$84M Buy
94,800
+39,900
+73% +$35.9M 0.12% 187
2024
Q2
$49.7M Sell
54,900
-59,400
-52% -$47.5M 0.08% 293
2024
Q1
$88.9M Buy
114,300
+49,800
+77% +$35.4M 0.14% 177
2023
Q4
$37.6M Buy
64,500
+45,900
+247% +$26.8M 0.07% 326
2023
Q3
$9.99M Buy
18,600
+12,200
+191% +$6.29M 0.03% 646
2023
Q2
$3M Buy
+6,400
New +$2.68M 0.01% 880
2023
Q1
Sell
-30,000
Closed -$11M 2823
2022
Q4
$11M Hold
30,000
0.06% 461
2022
Q3
$9.7M Buy
+30,000
New +$9.51M 0.06% 425

Other funds holding LLY

Qube Research & Technologies (QRT)'s LLY Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Eli Lilly (LLY) stake by 52% in Q2 2026, selling an estimated $377M and leaving 346,498 shares worth $416M. The position accounts for 0.39% of the portfolio, ranked #30.

Qube Research & Technologies (QRT) first reported a position in LLY in Q1 2018 and has held it in 28 quarters since. The position peaked at $658M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Qube Research & Technologies (QRT) held 346,498 shares of Eli Lilly worth $416M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 368,584 Eli Lilly shares in Q2 2026, an estimated $377M.
  • Eli Lilly made up 0.39% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #30 holding.
  • Qube Research & Technologies (QRT) first reported a position in Eli Lilly in Q1 2018 and has held it in 28 quarters since.
  • Qube Research & Technologies (QRT)'s Eli Lilly position peaked at $658M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.